PL3649259T3 - Multipleksowa analiza równoległa ze wzbogaceniem sekwencji docelowych do określania ryzyka stanów genetycznych - Google Patents

Multipleksowa analiza równoległa ze wzbogaceniem sekwencji docelowych do określania ryzyka stanów genetycznych

Info

Publication number
PL3649259T3
PL3649259T3 PL18745510.0T PL18745510T PL3649259T3 PL 3649259 T3 PL3649259 T3 PL 3649259T3 PL 18745510 T PL18745510 T PL 18745510T PL 3649259 T3 PL3649259 T3 PL 3649259T3
Authority
PL
Poland
Prior art keywords
risk
determining
target sequences
parallel analysis
enhancing target
Prior art date
Application number
PL18745510.0T
Other languages
English (en)
Inventor
George Koumbaris
Marios IOANNIDES
Kyriakos TSANGARAS
Charalambos LOIZIDES
Michalis Nicolaou
Skevi KYRIAKOU
Philippos PATSALIS
Elena Kypri
Original Assignee
Nipd Genetics Public Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipd Genetics Public Company Limited filed Critical Nipd Genetics Public Company Limited
Publication of PL3649259T3 publication Critical patent/PL3649259T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • C12Q1/6874Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
PL18745510.0T 2017-07-07 2018-07-06 Multipleksowa analiza równoległa ze wzbogaceniem sekwencji docelowych do określania ryzyka stanów genetycznych PL3649259T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762529785P 2017-07-07 2017-07-07
PCT/EP2018/068431 WO2019008167A1 (en) 2017-07-07 2018-07-06 MULTIPLEXED PARALLEL ANALYSIS ENRICHED IN TARGET FOR RISK ASSESSMENT FOR GENETIC DISORDERS

Publications (1)

Publication Number Publication Date
PL3649259T3 true PL3649259T3 (pl) 2022-08-08

Family

ID=63012986

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18745510.0T PL3649259T3 (pl) 2017-07-07 2018-07-06 Multipleksowa analiza równoległa ze wzbogaceniem sekwencji docelowych do określania ryzyka stanów genetycznych

Country Status (11)

Country Link
US (2) US11879157B2 (pl)
EP (2) EP4151750A1 (pl)
AU (1) AU2018296673B2 (pl)
CA (1) CA3068111A1 (pl)
CY (1) CY1125506T1 (pl)
DK (1) DK3649259T3 (pl)
ES (1) ES2925394T3 (pl)
PL (1) PL3649259T3 (pl)
PT (1) PT3649259T (pl)
WO (1) WO2019008167A1 (pl)
ZA (1) ZA201908558B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7836823B2 (ja) * 2020-12-18 2026-03-27 メディカバー バイオテック リミテッド サンプルを臨床関連カテゴリーに分類する方法
CN114990202B (zh) * 2022-07-29 2022-09-30 普瑞基准科技(北京)有限公司 Snp位点在评估基因组异常的应用及评估基因组异常的方法
CN116837090B (zh) * 2023-07-06 2024-01-23 东莞博奥木华基因科技有限公司 一种用于检测胎儿骨发育异常的引物组、试剂盒及方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3591068A1 (en) 2006-02-02 2020-01-08 The Board of Trustees of the Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
US20080194414A1 (en) 2006-04-24 2008-08-14 Albert Thomas J Enrichment and sequence analysis of genomic regions
WO2008027548A2 (en) * 2006-09-01 2008-03-06 Dana-Farber Cancer Institute, Inc. Microarray-based global chromatin structure mapping
CA3069082C (en) 2008-09-20 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US20110039304A1 (en) * 2009-08-12 2011-02-17 President And Fellows Of Harvard College Methods to Generate Oligonucleotide Pools and Enrich Target Nucleic Acid Sequences
CA2780827A1 (en) * 2009-12-31 2011-07-07 Ventana Medical Systems, Inc. Methods for producing uniquely specific nucleic acid probes
EP2370599B1 (en) 2010-01-19 2015-01-21 Verinata Health, Inc Method for determining copy number variations
US20120270739A1 (en) 2010-01-19 2012-10-25 Verinata Health, Inc. Method for sample analysis of aneuploidies in maternal samples
US20130123120A1 (en) * 2010-05-18 2013-05-16 Natera, Inc. Highly Multiplex PCR Methods and Compositions
EP3187597B1 (en) * 2011-02-09 2020-06-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20150203907A1 (en) * 2014-01-17 2015-07-23 Florida State University Research Foundation Genome capture and sequencing to determine genome-wide copy number variation
GB201414451D0 (en) * 2014-08-14 2014-10-01 Oxford Gene Technology Operations Ltd Hybridisation column for nucleic acid enrichment
WO2016040446A1 (en) * 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
EP3666902B1 (en) 2015-05-22 2024-07-03 Medicover Public Co Ltd Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
PT3649258T (pt) 2017-07-07 2022-05-25 Nipd Genetics Public Company Ltd Análise paralela multiplexada enriquecida com alvo para avaliação de amostras de adn fetal
ES2920280T3 (es) 2017-07-07 2022-08-02 Nipd Genetics Public Company Ltd Enriquecimiento de regiones genómicas blanco para análisis paralelo multiplexado

Also Published As

Publication number Publication date
PT3649259T (pt) 2022-06-15
EP4151750A1 (en) 2023-03-22
AU2018296673B2 (en) 2025-01-02
EP3649259B1 (en) 2022-05-25
CY1125506T1 (el) 2024-09-20
US20240200138A1 (en) 2024-06-20
ZA201908558B (en) 2022-06-29
AU2018296673A1 (en) 2020-01-16
WO2019008167A9 (en) 2019-04-11
US20210147937A1 (en) 2021-05-20
US11879157B2 (en) 2024-01-23
DK3649259T3 (da) 2022-08-15
EP3649259A1 (en) 2020-05-13
WO2019008167A1 (en) 2019-01-10
ES2925394T3 (es) 2022-10-17
CA3068111A1 (en) 2019-01-10

Similar Documents

Publication Publication Date Title
IL272466A (en) Antigen-binding proteins targeting shared antigens
DK3448990T3 (da) Forbedrede fremgangsmåder til modificering af målnukleinsyrer
DK3548652T3 (da) Fremgangsmåder til proteinanalyse
EP3454856C0 (en) HETEROCYCLIC DEGRONIMERS FOR DEGRADATION OF TARGET PROTEINS
DK3292137T3 (da) Proteiner specifikke for cd137
EP3733844A4 (en) COMPOSITION FOR MODIFYING A GOAL GENE
DK3901281T3 (da) Rumligt adskilt, multipleks nukleinsyreanalyse af biologiske prøver
DK3341482T3 (da) Kunstige nukleinsyremolekyler
DK3122897T3 (da) Detektering af målnukleinsyresekvenser under anvendelse af forskellige detekteringstemperaturer
MA56474A (fr) Contorsbody - liant de cible à chaîne unique
DK3237636T3 (da) Dobbelt-quenching analyse til multiplex detektion af målnukleinsyrer
DK3455625T3 (da) Fremgangsmåder til forudsigelse af anvendeligheden af neo-antigener til immunterapi
EP3349754A4 (en) PCNA INHIBITORS
CL2018000520A1 (es) Proteinas inhibidoras de insectos novedosas
EP3342431C0 (en) AUTONOMOUS BIOLOGICAL INDICATOR
PT3666902T (pt) Análise paralela multiplexada de regiões genómicas alvo para testes pré-natais não invasivos
EP3380637A4 (en) DETERMINATION OF NUCLEIC ACID METHYLATION
EP3351655A4 (en) sputter target
EP3436605C0 (en) AMPLIFICATION OF TARGET SEQUENCES
DK3340796T3 (da) Sonder til afbildning af huntingtin-protein
EP3751266A4 (en) SAMPLE HOLDER
KR20180085061A (ko) 타겟 핵산 서열에 대한 시그널 추출
PT3644728T (pt) Congelamento de material biológico
EP3444163A4 (en) TARGET FUNDING VEHICLE
DK3271864T3 (da) Vævsprøveanalyseteknik